Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • January 20, 2024

Tangri N, Rastogi A, Nekeman-Nan C, Hong LS, Ozaki A, Franzén S, Sofue T. Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Jan 19. doi: 10.1007/s12325-023-02773-x. Epub ahead of print. PMID: 38240949.

Tags: Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT2I

Using a generative co-design framework to adapt an exercise intervention as part of a multimodal intervention for patients’ receiving haemodialysis with or at risk of renal cachexia

Blair C, Slee A, McKeaveney C, Maxwell AP, Awan F, Brown M, Carson M, Comer S, Davenport A, Fogarty D, Fouque D, Gooding O, McKinley[...]

How Far Is a Kidney Willing to Go? Kidney Transplant Outcomes Based on Distance Donor Kidney Travels to Transplant Centers

Datta N, Qureshi A, Ebadyrad M, Thi Pham PT, Hamiduzzaman A, Pirzadeh A, Velazquez A, Bunnapradist S, Lum EL. How Far Is a Kidney Willing[...]

Kassem Safa, MD Appointed Medical Director of the UCLA Kidney Transplant Program

The UCLA Department of Medicine has appointed Kassem Safa, MD, as medical director of the UCLA Kidney Transplant Program in the division of nephrology, effective[...]